Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-15

Clinical Trial Update: Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis [NA]

View source ↗

Summary

A completed clinical trial compared baricitinib to azathioprine in patients with moderate-to-severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • Baricitinib (baricitinib)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Atopic Dermatitis | NA | Status: COMPLETED